AC 3092

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 524129

CAS#: 7558-14-7

Description: AC 3092 is a bio-active chemical.


Chemical Structure

img
AC 3092
CAS# 7558-14-7

Theoretical Analysis

MedKoo Cat#: 524129
Name: AC 3092
CAS#: 7558-14-7
Chemical Formula: C20H25N5O3
Exact Mass: 383.20
Molecular Weight: 383.440
Elemental Analysis: C, 62.65; H, 6.57; N, 18.26; O, 12.52

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: AC 3092; AC3092; AC-3092;

IUPAC/Chemical Name: 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(2-(4-morpholinyl)ethyl)-8-(phenylmethyl)-

InChi Key: XKKXBBFOYVNTDX-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H25N5O3/c1-22-18-17(19(26)23(2)20(22)27)25(9-8-24-10-12-28-13-11-24)16(21-18)14-15-6-4-3-5-7-15/h3-7H,8-14H2,1-2H3

SMILES Code: O=C(N1C)N(C)C2=C(N(CCN3CCOCC3)C(CC4=CC=CC=C4)=N2)C1=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 383.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Won da H, Choi CH, Chung J, Chung MW, Kim EH, Woo SI. Rational Design of a Hierarchical Tin Dendrite Electrode for Efficient Electrochemical Reduction of CO2. ChemSusChem. 2015 Sep 21;8(18):3092-8. doi: 10.1002/cssc.201500694. Epub 2015 Jul 27. PubMed PMID: 26219092.

2: Todokoro D, Eguchi H, Yamada N, Sodeyama H, Hosoya R, Kishi S. Contact Lens-Related Infectious Keratitis with White Plaque Formation Caused by Corynebacterium propinquum. J Clin Microbiol. 2015 Sep;53(9):3092-5. doi: 10.1128/JCM.00899-15. Epub 2015 Jul 15. PubMed PMID: 26179302; PubMed Central PMCID: PMC4540905.

3: Layani-Bazar A, Skornick I, Berrebi A, Pauker MH, Noy E, Silberman A, Albeck M, Longo DL, Kalechman Y, Sredni B. Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state. Cancer Res. 2014 Jun 1;74(11):3092-103. doi: 10.1158/0008-5472.CAN-13-2159. Epub 2014 Apr 3. PubMed PMID: 24699624.

4: Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF; ATAC/LATTE investigators. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010 Dec;11(12):1135-41. doi: 10.1016/S1470-2045(10)70257-6. Epub 2010 Nov 17. PubMed PMID: 21087898.

5: Levy DE, Bao M, Cherbavaz DB, Tomlinson JE, Sedlock DM, Homcy CJ, Scarborough RM. Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists. J Med Chem. 2003 May 22;46(11):2177-86. PubMed PMID: 12747789.

6: Margetts BM, Mohd Yusof S, Al Dallal Z, Jackson AA. Persistence of lower birth weight in second generation South Asian babies born in the United Kingdom. J Epidemiol Community Health. 2002 Sep;56(9):684-7. PubMed PMID: 12177085; PubMed Central PMCID: PMC1732245.

7: Neunteufl T, Heher S, Stefenelli T, Pabinger I, Gisslinger H. Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol. 2001 Nov;115(2):354-9. PubMed PMID: 11703335.

8: Staynov DZ. DNase I digestion reveals alternating asymmetrical protection of the nucleosome by the higher order chromatin structure. Nucleic Acids Res. 2000 Aug 15;28(16):3092-9. PubMed PMID: 10931924; PubMed Central PMCID: PMC108430.

9: Kariyama R, Mitsuhata R, Chow JW, Clewell DB, Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol. 2000 Aug;38(8):3092-5. PubMed PMID: 10921985; PubMed Central PMCID: PMC87194.

10: Frankenburg S, Glick D, Klaus S, Barenholz Y. Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B. Antimicrob Agents Chemother. 1998 Dec;42(12):3092-6. PubMed PMID: 9835496; PubMed Central PMCID: PMC106004.

11: Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):351-6. PubMed PMID: 8630658.

12: Neminsky AM, Nikolaev PN, Shovkun DV, Laukhina EE, Yagubskii EB. Temperature dependence of the magnetic field penetration depth in Rb3C60 measured by ac susceptibility. Phys Rev Lett. 1994 May 9;72(19):3092-3095. PubMed PMID: 10056065.

13: Georges A, Dusart P, Gerin Y, Denef J. [Toxicological study of the choleretic L-H-4,5,6,7-tetrahydro-2-benzyl-L-(morpholino-2-aminoethyl)-4,5-dimethyl-5,7-diox o-imidazo-4,5-d-pyrimidine (AC 3092)]. Arzneimittelforschung. 1969 Jul;19(7):1113-8. German. PubMed PMID: 5395533.

14: Georges A, Dusart P, Denef J. [Effect of AC 3092 in strong doses on glycemia]. Arch Int Pharmacodyn Ther. 1969 Apr;178(2):251-68. French. PubMed PMID: 4390989.

15: Georges A, Foucart G, Page J, Duvernay G. [Evaluation of the choleretic properties of AC 3092]. Arch Int Pharmacodyn Ther. 1966 Aug;162(2):447-68. French. PubMed PMID: 5968523.